eXoZymes, Inc.(EXOZ)

Biotechnology · Monrovia, CA

$5.54+0.02 (+0.36%)

Delayed quote: Oct 6, 2026, 11:59 AM EDT

eXoZymes (EXOZ) EV/EBITDA: History & Chart | TGMCharts

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T17:02:10.223Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:02:10.223Z.

Quote observation: 2026-10-06T15:59:37.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 51,418,729
Total debt · period ending 2026-06-30: 1,085,035
Cash · period ending 2026-06-30: 5,652,696
TTM operating EBITDA · period ending 2026-06-30: -10,262,264

FMP input reference: 787788ea5c712995087b0511470a3bc1500b131fb4a88c1f5ff44ca2612ce4c8

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

EXOZ EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

EXOZ Competitors' EV/EBITDA Ratio

EXOZ

eXoZymes, Inc.

Current

Market Cap

$51.42M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COCH

Envoy Medical, Inc.

vs EXOZ

Market Cap

$51.33M

EV/EBITDA Ratio

N/A

TTM Avg

335.70x

3Y Avg

335.70x

5Y Avg

335.70x

ELOX

Eloxx Pharmaceuticals, Inc.

vs EXOZ

Market Cap

$51.54M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RANI

Rani Therapeutics Holdings, Inc.

vs EXOZ

Market Cap

$51.24M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs EXOZ

Market Cap

$51.61M

EV/EBITDA Ratio

9.09x

TTM Avg

5.34x

3Y Avg

6.36x

5Y Avg

5.55x

CELU

Celularity Inc.

vs EXOZ

Market Cap

$50.80M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLNN

Clene Inc.

vs EXOZ

Market Cap

$50.54M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

APLM

Apollomics, Inc.

vs EXOZ

Market Cap

$50.18M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DWTX

Dogwood Therapeutics, Inc.

vs EXOZ

Market Cap

$52.46M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NMAD

NOMAD Power Solutions, Inc.

vs EXOZ

Market Cap

$52.47M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
eXoZymes, Inc. (EXOZ)	$51.42M	N/A	N/A	N/A	N/A
Envoy Medical, Inc. (COCH)vs ›	$51.33M	N/A	335.70x	335.70x	335.70x
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$51.54M	N/A	N/A	N/A	N/A
Rani Therapeutics Holdings, Inc. (RANI)vs ›	$51.24M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$51.61M	9.09x	5.34x	6.36x	5.55x
Celularity Inc. (CELU)vs ›	$50.80M	N/A	N/A	N/A	N/A
Clene Inc. (CLNN)vs ›	$50.54M	N/A	N/A	N/A	N/A
Apollomics, Inc. (APLM)vs ›	$50.18M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$52.46M	N/A	N/A	N/A	N/A
NOMAD Power Solutions, Inc. (NMAD)vs ›	$52.47M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics